GREGORY BURZYNSKI: Open Payments
NPI 1952592131 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 45 payments from 15 companies in 2025. Trend: 2023 $614 · 2024 $891 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 19 | $136 |
| Indivior Inc. | 5 | $135 |
| ViiV Healthcare Company | 3 | $100 |
| Tempus AI, Inc | 3 | $69 |
| Lilly USA, LLC | 2 | $48 |
| PFIZER INC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Gilead Sciences, Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
Products named: FREESTYLE LIBRE 3, SUBLOCADE, APRETUDE, XT CDX, JARDIANCE, NURTEC ODT, SARCLISA, OTEZLA.
Industry payments across TX — which companies pay providers there.
